FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics

Group 1 - A federal securities class action has been filed against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) [1] - Faruqi & Faruqi, LLP is investigating potential claims related to the company [1] - Investors are reminded of the October 14, 2025 deadline to seek the role of lead plaintiff in the class action [1]